Company Overview of Banyan Biomarkers, Inc.
Banyan Biomarkers, Inc. develops biomarkers for the diagnosis, management, and treatment of traumatic brain injuries (TBIs). Its product pipeline includes biomarkers for stroke, depression, hypoxic ischemic encephalopathy (HIE), neuro ICU monitoring, and subacute/chronic TBI. The company also provides a point-of-care diagnostic blood test to detect the presence of mild and moderate brain trauma of head injured patients. Banyan Biomarkers, Inc. was formerly known as Daimonion Diagnostics, LLC and changed its name to Banyan Biomarkers, Inc. in July 2004. The company was founded in 2002 and is based in Alachua, Florida with an additional location in San Diego, California.
13400 Progress Boulevard
Alachua, FL 32615
Founded in 2002
Key Executives for Banyan Biomarkers, Inc.
Banyan Biomarkers, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Banyan Biomarkers, Inc., please visit www.banyanbio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.